ITGAV and neoplasm: As a result, miR-146a is able to exert a paradoxical role in melanoma tumor cells: while it inhibits tumor metastasis through ITGAV inhibition, at the same time it favors tumor growth through the activation of the AKT/PTEN pathway [54].